IPC’S PLAN FOR ADVANCING KNOWLEDGE AND IMPROVING CARE FOR PEOPLE WITH PSORIASIS
Our mission is to improve the health and well-being of people with psoriasis and associated diseases worldwide through education, research, and advocacy.
Our vision is a world free of the burden of psoriasis. People with psoriasis worldwide should have access to the best available care and be empowered to lead healthy, fulfilling lives.
Global Approach: Our international mandate drives us to understand regional contexts and collaborate globally on all aspects of psoriasis.
Collaboration: We engage and foster ongoing discussions and knowledge exchange with all stakeholders, including professional societies, regulatory authorities, public and patient organizations, and corporations.
Unbiased Approach: Our work is based on objective, scientific evidence and information, ensuring impartiality and credibility.
Impact-Driven: Our focus is improving patient outcomes, regardless of geographical location or resource limitations.
Patient Perspective: We collaborate with patients and advocacy organizations to integrate patients’ voices and prioritize their needs.
Diversity: We value diversity in all forms and are committed to fostering an inclusive environment that embraces individuals of different backgrounds, cultures, sexes/genders, and ages.
We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.
How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.
Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.
